Chiu‐Ching Huang

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

Éric Rondeau, Marie Scully, Gema Ariceta et al. · Kidney International · 2020 · 219 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Metformin-associated lactic acidosis: case reports and literature review.

Chin-Tung Chang, Yung‐Chang Chen, Ji‐Tseng Fang et al. · PubMed · 2003 · 111 citations

Life Sciences, Pathobiology, Clinical Nutrition +8

Peptic Ulcer Disease Risk in Chronic Kidney Disease: Ten-Year Incidence, Ulcer Location, and Ulcerogenic Effect of Medications

Chih‐Chia Liang, Chih‐Hsin Muo, I‐Kuan Wang et al. · PLoS ONE · 2014 · 70 citations · Full text

Medicine, Geriatric Medicine, Nephrology +14

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults

Thomas Barbour, Marie Scully, Gema Ariceta et al. · Kidney International Reports · 2021 · 66 citations · Full text

Life Sciences, Hematology, Pharmacotherapy +17

IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy

Huey‐Liang Kuo, Chiu‐Ching Huang, Tze‐Yi Lin et al. · Nephrology Dialysis Transplantation · 2016 · 54 citations · Full text

Medicine, Immunology, Nephrology +17